By Drug Target Review2025-06-30T13:30:47
Researchers have developed a new method to generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA to T cells - offering a safer, faster and more accessible alternative to traditional cell therapies for cancer and autoimmune diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2023-11-20T13:43:43
Sponsored by Merck
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-04-12T15:28:08
Sponsored by nanoComposix
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-05-14T14:30:00
Sponsored by Abzena
Site powered by Webvision Cloud